MyFinsight
Home
About
Contact
rytm: the income statement
Download
Download image
Net loss
attributable to common...
-$54,279K
(-20.70%↓ Y/Y)
Accrued dividends on
convertible preferred stock
$1,375K
(3.46%↑ Y/Y)
Net loss
-$52,904K
(-21.23%↓ Y/Y)
Non Us
$13,084K
US
$38,214K
Provision for income taxes
$111K
(132.27%↑ Y/Y)
Loss before income
taxes
-$52,793K
(-20.03%↓ Y/Y)
Revenue From Contract
With Customer...
$51,298K
Total other
(expense), net
-$140K
(-40.00%↓ Y/Y)
Loss from operations
-$52,653K
(-19.98%↓ Y/Y)
Interest income
$4,328K
(6.76%↑ Y/Y)
Other income
(expense), net
$274K
(-74.82%↓ Y/Y)
Total revenues
$51,298K
(54.28%↑ Y/Y)
Interest expense
$4,742K
(-9.54%↓ Y/Y)
Total costs and
expenses
$103,951K
(34.76%↑ Y/Y)
Selling, general, and
administrative
$52,425K
(48.19%↑ Y/Y)
Research and development
$46,027K
(21.34%↑ Y/Y)
Cost of sales
$5,499K
(43.65%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
RHYTHM PHARMACEUTICALS, INC. (RYTM)
RHYTHM PHARMACEUTICALS, INC. (RYTM)